Keys to unlock cancer: targeted therapy.
Viele
Carol S
CS
University of California, San Francisco Medical Center, USA. csviele@aol.com
D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D016503:Drug Delivery Systems / Q000379:methods*; D004791:Enzyme Inhibitors / Q000008:administration & dosage; D066246:ErbB Receptors / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D008024:Ligands; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism / Q000451:nursing; D009389:Neovascularization, Pathologic / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism; D009859:Oncology Nursing / Q000379:methods; D042461:Vascular Endothelial Growth Factor A / Q000187:drug effects / Q000378:metabolism
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D008024:Ligands; D042461:Vascular Endothelial Growth Factor A; D066246:ErbB Receptors